INTRODUCTION
Cancer is one of the leading causes of death worldwide, both in developed and developing countries. There were more than fourteen millions new cases of cancer and more than eight millions deaths from cancer worldwide in 2012 alone. Developing countries account for 57% of new cancer cases and 65% of cancer deaths.1 Based on Globocan 2012, estimated cancer incidence in Indonesia is 134 per 100000 residents. 1 In the 2013 Basic Health Research (Riskesdas), the prevalence of cancer patients in all ages in Indonesia was 1.4 per 1000 inhabitants.2 In January to June 2014, cancer treatments ranked second and fifth in regard of treat-ments compared to other hospitalization disease.3 NPC, as the most common neck and head malignancy, is the fourth most common cancer in Indonesia. Estimated regional NPC incidence from 11 centers in Indonesia is 5.66 per 100000, or about 1000 new cases every month. It is estimated that there are still many cases that are not recorded due to various factors, such as limited resources and facilities of the hospital, and the absence of a national cancer registration system.4 To date, population-based cancer registry (PBCR) system is not yet available in Indonesia. In many developing countries, cancer registration system begins with the formation of a hospital-based cancer registry (HBCR) in several hospitals.5 Data from the Cipto Mangunkusumo National Hospital (CMNH) HBCR as a national referral center hospital will be very beneficial for the development of PBCR in Indonesia.
METHODS
This study was a descriptive and retrospective comparative analysis of NPC patients, based on CMNH HBCR year 2013. This study used total sampling method. We collected and analyzed patients' data regarding demographic, basis of diagnosis, staging, histopathological type and treatments. Missing or incomplete data were then being complemented from medical record. Gathered data then would be put together and presented in percentage.
RESULTS
A total of 299 NPC patients' data were collected from CMNH HBCR year 2013. Demographic characteristics of age and sex can be traced in all patients. Of the 299 patients, 124 patients had ethnic / racial data, and 264 patients had domicile data. Tumor characteristics collected were histopathology and staging groups. 280 patients had histopathology data, and 233 patients had stage data. Based on the CMNH HBCR year 2013, 299 patients were diagnosed as nasopharyngeal cancer. As many as 212 patients (70.9%) were male and 87 (29.1%) were female. Age peaks at 51-55 (figure 1), with a median age of 47 years, the youngest was 10 years and the oldest was 77 years. Most patients came from outside Jakarta. Most patients identify as non-chinese (38.8%), with 58.5% data regarding ethnicities is not available. More complete demographic characteristics data can be seen in table 1. The most common basis for diagnosis is through histopathological examination of the primary tumor (91%, n = 272), clinical examination (3%, n = 10), followed by the diagnosis of histopathology based on metastasis lesion (2.7%, n = 8) and radiology (2.7%, n = 8). Basis of diagnosis data is shown in table 2. ranked third and fourth, as many as 6.1% (n = 17) and 2.1% (n = 6). As many as 19 (6.8%) patients did not have any histopathological data due to inavailability primary tumor histopathological examination or due to incomplete medical record. NPC histopathological distribution can be seen in table 3. 
